Literature DB >> 22568530

Evaluation of the anti-Leishmania activity of ethanol extract and fractions of the leaves from Pityrogramma calomelanos (L.) link.

Teógenes M Souza1, Maria Flaviana B Morais-Braga, Antônio Álamo F Saraiva, Miriam Rolón, Celeste Vega, Antonieta Rojas de Arias, José Galberto M Costa, Irwin Rose A Menezes, Henrique D M Coutinho.   

Abstract

Leishmaniasis is caused by parasites of the genus Leishmania. Recent reports about leishmaniasis show a few number of drugs available, indicating the necessity of new drugs. In this study, the ethanol extract and fractions of Pityrogramma calomelanos (L.) link. (Pteridaceae) were assayed to verify the cytotoxicity and in vitro leishmanicidal activity against promastigote forms of Leishmania brasiliensis. The cytotoxic assay was performed using fibroblasts NCTC929. The studies indicated a leishmanicidal effect of the ethanol extract and the ethyl-acetate fraction. However, a high cytotoxic effect was observed. The hexane and methanol fractions did not show leishmanicidal activity, nor cytotoxic effect. The phytochemical screening detected the presence of alkaloids, a class of secondary metabolites with a known leishmanicidal activity. This is the first study reporting an anti-Leishmania and cytotoxic effect of P. calomelanos, being an interesting approach in the search for drugs against this disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22568530     DOI: 10.1080/14786419.2012.686911

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  1 in total

1.  4-(1H-Pyrazol-1-yl) benzenesulfonamide derivatives: identifying new active antileishmanial structures for use against a neglected disease.

Authors:  Roberta K F Marra; Alice M R Bernardino; Tathiane A Proux; Karen S Charret; Marie-Luce F Lira; Helena C Castro; Alessandra M T Souza; Cesar D Oliveira; Júlio C Borges; Carlos R Rodrigues; Marilene M Canto-Cavalheiro; Leonor L Leon; Veronica F Amaral
Journal:  Molecules       Date:  2012-11-01       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.